All Systems Go At Almirall To Enter Tough Atopic Dermatitis Market With Ebglyss

 
• By Kevin Grogan

Following a positive opinion from the CHMP, the Spanish company is hoping to launch its challenger to Dupixent in the EU before the end of the year.

Meninas
A Reimagining Of Velázquez’s Las Meninas challenging the myth that atopic dermatitis is only a pediatric problem • Source: Almirall

More from Immunological

More from Therapy Areas